PHASE 1, OPEN-LABEL, DOSE-FINDING STUDY OF CC-90009, A NOVEL CEREBLON E3 LIGASE MODULATING DRUG, IN SUBJECTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA February 15, 2018 Type of Cancer Head and Neck Sponsor Pfizer Protocol Number Pfized B9991016 To Learn More Call (201)-510-0950
